4.7 Article

Enduring Reactive Oxygen Species Emission Causes Aberrant Protein S-Glutathionylation Transitioning Human Aortic Valve Cells from a Sclerotic to a Stenotic Phenotype

Journal

ANTIOXIDANTS & REDOX SIGNALING
Volume 37, Issue 13, Pages 1051-1071

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2021.0133

Keywords

calcific aortic valve stenosis; endothelial cells; oxidative stress; protein S-glutathionylation; antioxidants; calcification

Funding

  1. Italian Ministry of Health funds [GR-2018-12366423]
  2. Fondazione Gigi e Pupa Ferrari ONLUS [FPF-14]
  3. T32 NIH training grant [T32AG058527]
  4. Johns Hopkins University Older American Independence Center of the National Institute on Aging (NIA) [P30AG021334]
  5. NIH [R01 HL136918]

Ask authors/readers for more resources

This study investigates the role of oxidative stress and endothelial dysfunction in the progression of calcific aortic valve stenosis (CAVS). The results indicate that oxidation-induced protein S-glutathionylation (P-SSG) contributes to the phenotypic switch in human aortic valvular tissue, leading to calcium deposition. The use of antioxidants can prevent these alterations.
Aims: During calcific aortic valve stenosis (CAVS) progression, oxidative stress and endothelial dysfunction mark the initial pathogenic steps with a parallel dysregulation of the antioxidant systems. Here, we tested whether oxidation-induced protein S-glutathionylation (P-SSG) accounts for a phenotypic switch in human aortic valvular tissue, eventually leading to calcium deposition. Next, we tested whether countering this reactive oxygen species (ROS) surge would prevent these perturbations. Results: We employed state-of-the-art technologies, such as electron paramagnetic resonance (EPR), liquid chromatography-tandem mass spectrometry, imaging flow-cytometry, and live-cell imaging on human excised aortic valves and primary valve endothelial cells (VECs). We observed that a net rise in EPR-detected ROS emission marked the transition from fibrotic to calcific in human CAVS specimens, coupled to a progressive increment in P-SSG deposition. In human VECs (hVECs), treatment with 2-acetylamino-3-[4-(2-acetylamino2-carboxyethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl]propionic acid triggered highly oxidizing conditions prompting P-SSG accumulation, damaging mitochondria, and inducing endothelial nitric oxide synthase uncoupling. All the events conjured up in morphing these cells from their native endothelial phenotype into a damaged calcification-inducing one. As proof of principle, the use of the antioxidant N-acetyl-L-cysteine prevented these alterations. Innovation: Borne as a compensatory system to face excessive oxidative burden, with time, P-SSG contributes to the morphing of hVECs from their innate phenotype into a damaged one, paving the way to calcium deposition. Conclusion: Our data suggest that, in the human aortic valve, unremitted ROS emission along with a P-SSG build-up occurs and accounts, at least in part, for the morphological/functional changes leading to CAVS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available